Phase 2 CAR-T Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Leukemia RelapseLymphoma Diffuse Large B-cellLeukemia and Lymphoma+1 more

AvenCell Therapeutics, Inc.178 enrolled13 locationsNCT07284433

Recruiting

Phase 2

Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

Prolonged Cytopenia Following CAR-T Therapy

Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07127289

Recruiting

Phase 2

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy

Seoul National University Hospital50 enrolled1 locationNCT06247501